ALL-REZ BFM 2002 is associated with improved outcome as compared to ALL-R3 strategy in children with standard risk isolated cns relapse of acute lymphoblastic leukemia, while maintaining comparable efficacy in patients with bone marrow relapse. results of the multi-national, multi-center Trial IntReALL SR 2010
von Stackelberg, A. Bourquin, J. P. Zimmermann, M. Revesz, T. Attarbaschi, A. Ferster, A. Sramkova, L. Frandsen, T. L. Lahteenmaki, P. M. Elhasid, R.
von Stackelberg, A.
Bourquin, J. P.
Zimmermann, M.
Revesz, T.
Attarbaschi, A.
Ferster, A.
Sramkova, L.
Frandsen, T. L.
Lahteenmaki, P. M.
Elhasid, R.
Citations
Altmetric:
Abstract
Authors
von Stackelberg, A.
Bourquin, J. P.
Zimmermann, M.
Revesz, T.
Attarbaschi, A.
Ferster, A.
Sramkova, L.
Frandsen, T. L.
Lahteenmaki, P. M.
Elhasid, R.
Toyoda, H.
Hoogerbrugge, P. M.
Johannsdottir, I. M.
Duarte, X.
Bonney, D.
Saha, Vaskar
Steffen, I. G.
Lissat, A.
Chen-Santel, C.
Eckert, C.
Baruchel, A.
Petit, A.
Cave, H.
Rizzari, C.
Cazzaniga, G.
Vinti, L.
Rohrlich, P.
Locatelli, F.
Bourquin, J. P.
Zimmermann, M.
Revesz, T.
Attarbaschi, A.
Ferster, A.
Sramkova, L.
Frandsen, T. L.
Lahteenmaki, P. M.
Elhasid, R.
Toyoda, H.
Hoogerbrugge, P. M.
Johannsdottir, I. M.
Duarte, X.
Bonney, D.
Saha, Vaskar
Steffen, I. G.
Lissat, A.
Chen-Santel, C.
Eckert, C.
Baruchel, A.
Petit, A.
Cave, H.
Rizzari, C.
Cazzaniga, G.
Vinti, L.
Rohrlich, P.
Locatelli, F.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
von Stackelberg A, Bourquin JP, Zimmermann M, Revesz T, Attarbaschi A, Ferster A, et al. ALL-REZ BFM 2002 Is Associated with Improved Outcome as Compared to ALL-R3 Strategy in Children with Standard Risk Isolated CNS Relapse of Acute Lymphoblastic Leukemia, while Maintaining Comparable Efficacy in Patients with Bone Marrow Relapse. Results of the Multi-National, Multi-Center Trial IntReALL SR 2010. Blood. 2022 Nov;140:3247-9. PubMed PMID: WOS:000893223203127.